Becton Dickinson PE Ratio 2010-2023 | BDX

Current and historical p/e ratio for Becton Dickinson (BDX) from 2010 to 2023. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Becton Dickinson PE ratio as of April 19, 2024 is 19.64.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Becton Dickinson PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2024-04-19 234.12 55.48
2023-12-31 242.86 $4.22 57.55
2023-09-30 256.46 $4.96 51.71
2023-06-30 261.00 $5.51 47.37
2023-03-31 243.83 $5.33 45.75
2022-12-31 249.51 $5.30 47.08
2022-09-30 217.84 $4.44 49.06
2022-06-30 240.20 $5.24 45.84
2022-03-31 251.90 $5.00 50.38
2021-09-30 231.21 $6.85 33.75
2021-06-30 228.01 $6.37 35.79
2021-03-31 227.19 $6.93 32.78
2020-12-31 233.00 $6.96 33.48
2020-09-30 215.92 $4.14 52.15
2021-12-31 237.37 $4.65 51.05
2020-06-30 221.29 $2.78 79.60
2020-03-31 211.82 $3.32 63.80
2019-12-31 249.87 $2.72 91.86
2019-09-30 231.70 $3.90 59.41
2019-06-30 230.15 $2.85 80.75
2019-03-31 227.33 $3.37 67.46
2018-12-31 204.47 $3.25 62.91
2018-09-30 236.07 $0.44 536.53
2018-06-30 216.05 $2.32 93.12
2018-03-31 194.80 $-0.46 0.00
2017-12-31 191.78 $1.31 146.40
2017-09-30 174.95 $4.65 37.62
2017-06-30 173.57 $3.50 49.59
2017-03-31 162.57 $6.05 26.87
2016-12-31 146.13 $6.03 24.23
2016-09-30 157.95 $4.51 35.02
2016-06-30 148.49 $5.26 28.23
2016-03-31 132.41 $3.75 35.31
2015-12-31 133.79 $3.27 40.91
2015-09-30 114.69 $3.74 30.67
2015-06-30 121.92 $4.55 26.80
2015-03-31 123.06 $5.71 21.55
2014-09-30 96.72 $6.00 16.12
2014-06-30 100.07 $4.93 20.30
2014-03-31 98.59 $4.80 20.54
2013-12-31 92.60 $4.74 19.54
2013-09-30 83.40 $6.50 12.83
2013-06-30 82.00 $7.47 10.98
2013-03-31 78.93 $7.54 10.47
2012-12-31 64.19 $7.54 8.51
2012-09-30 64.08 $5.62 11.40
2012-06-30 60.61 $5.55 10.92
2012-03-31 62.58 $5.49 11.40
2011-12-31 59.86 $5.48 10.92
2011-09-30 58.38 $5.63 10.37
2011-06-30 68.26 $5.95 11.47
2011-03-31 62.77 $5.71 10.99
2010-12-31 66.29 $5.57 11.90
2010-09-30 57.82 $5.51 10.49
2010-06-30 52.49 $5.12 10.25
2010-03-31 60.79 $5.22 11.65
2009-12-31 60.60 $5.04 12.02
2009-09-30 53.35 $4.94 10.80
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $67.638B $19.372B
Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional. BD Medical: BD Medical's major product lines include needles, syringes and intravenous catheters for medication delivery and generic prefilled injectables. BD Life Sciences - BD Diagnostics provides products for the safe collection and transport of diagnostics specimens to detect a broad range of infectious diseases, healthcare-associated infections and cancer. BD Biosciences produces research and clinical tools that facilitate the study of cells to gain a better understanding of normal and disease processes. With the acquisition of C.R. Bard, BD added a new segment - BD Interventional.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $68.967B 18.46
West Pharmaceutical Services (WST) United States $27.235B 46.04
Cardinal Health (CAH) United States $26.315B 15.82
Align Technology (ALGN) United States $22.499B 45.37
Cooper (COO) United States $17.972B 27.19
Labcorp (LH) United States $16.950B 14.47
Henry Schein (HSIC) United States $9.104B 15.75
DENTSPLY SIRONA (XRAY) United States $6.325B 16.67
Merit Medical Systems (MMSI) United States $4.182B 23.93
Patterson (PDCO) United States $2.331B 11.17
STAAR Surgical (STAA) United States $2.267B 71.37
CONMED (CNMD) United States $2.237B 21.06
Atrion (ATRI) United States $0.708B 36.48
Lifevantage (LFVN) United States $0.086B 13.96
Pro-Dex (PDEX) United States $0.067B 25.33
Biolase (BIOL) United States $0.005B 0.00